Literature DB >> 26449831

MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.

Ruyi Zhang1, Shujuan Yan1, Jing Wang1, Fang Deng1, Yangliu Guo1, Ya Li1, Mengtian Fan1, Qilin Song1, Hongxia Liu1, Yaguang Weng2, Qiong Shi3.   

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor in young patients. However, treatment paradigms and survival rates have not improved in decades. MicroRNAs have been shown to be critical regulators of physiological homeostasis and pathological process, including bone disease. Nearly half of the microRNA (miRNA) genes are located at genomic regions and fragile sites known to be frequently deleted or amplified in various kinds of cancers. In this study, we investigated the role miR-30a in OS. A negative correlation between miR-30a expression and malignant grade was observed in OS cell lines. The overexpression of miR-30a reduced proliferation, migration, and invasion in 143B cells and the inhibitor of miR-30a increased proliferation, migration, and invasion in Saos2 cells. Further studies revealed that runt-related transcription factors 2 (Runx2) was a regulative target gene of miR-30a. Rescue assay significantly reversed the effects of overexpressing or inhibiting miR-30a. miR-30a also suppressed tumor formation and pulmonary metastasis in vivo. All the results suggest a critical role of miR-30a in suppressing proliferation, migration, and invasion of OS by targeting Runx2.

Entities:  

Keywords:  Invasion; Migration; Osteosarcoma; Proliferation; Runx2; miR-30a

Mesh:

Substances:

Year:  2015        PMID: 26449831     DOI: 10.1007/s13277-015-4086-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

Review 2.  Role and regulation of RUNX2 in osteogenesis.

Authors:  M Bruderer; R G Richards; M Alini; M J Stoddart
Journal:  Eur Cell Mater       Date:  2014-10-23       Impact factor: 3.942

3.  A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma.

Authors:  Crispin R Dass; Eugene T Ek; Karla G Contreras; Peter F Choong
Journal:  Clin Exp Metastasis       Date:  2006-12-23       Impact factor: 5.150

4.  Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma.

Authors:  Y U Chen; Song-Feng Xu; Ming Xu; Xiu-Chun Yu
Journal:  Mol Clin Oncol       Date:  2015-03-09

5.  Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.

Authors:  Margaretha van der Deen; Jacqueline Akech; David Lapointe; Sneha Gupta; Daniel W Young; Martin A Montecino; Mario Galindo; Jane B Lian; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

6.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

7.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

8.  miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.

Authors:  Ying Ma; Xing-guo She; Ying-zi Ming; Qi-quan Wan
Journal:  Tumour Biol       Date:  2014-07-30

9.  MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.

Authors:  Xiaozhen Zhang; Marybeth Daucher; David Armistead; Rodney Russell; Shyam Kottilil
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.

Authors:  C Ge; G Zhao; Y Li; H Li; X Zhao; G Pannone; P Bufo; A Santoro; F Sanguedolce; S Tortorella; M Mattoni; S Papagerakis; E T Keller; R T Franceschi
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

View more
  23 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.

Authors:  Ming Zhao; Dingya Sun; Yangtai Guan; Zhihong Wang; Daoqian Sang; Mingdong Liu; Yingyan Pu; Xue Fang; Dan Wang; Aijun Huang; Xiaoying Bi; Li Cao; Cheng He
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

3.  MicroRNA-221 is involved in the regulation of osteoporosis through regulates RUNX2 protein expression and osteoblast differentiation.

Authors:  Yinquan Zhang; Yulei Gao; Lijun Cai; Fengning Li; Yi Lou; Ning Xu; Yifan Kang; Huilin Yang
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

Review 4.  MicroRNAs in Bone Metastasis.

Authors:  Eric Hesse; Hanna Taipaleenmäki
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

5.  Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.

Authors:  Jiang-Hua Dai; Wen-Zhou Huang; Chen Li; Jun Deng; Si-Jian Lin; Jun Luo
Journal:  Cell Cycle       Date:  2019-08-21       Impact factor: 4.534

Review 6.  Runx2 and microRNA regulation in bone and cartilage diseases.

Authors:  Weiwei Zhao; Shanxing Zhang; Baoli Wang; Jian Huang; William W Lu; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2016-08-15       Impact factor: 5.691

7.  MICROmanagement of Runx2 Function in Skeletal Cells.

Authors:  Benjamin J Wildman; Tanner C Godfrey; Mohammad Rehan; Yuechuan Chen; Lubana H Afreen; Quamarul Hassan
Journal:  Curr Mol Biol Rep       Date:  2019-01-24

8.  MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.

Authors:  Yuanlong Xie; Wenchao Sun; Zhouming Deng; Xiaobin Zhu; Chao Hu; Lin Cai
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

9.  MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2.

Authors:  Xi Xie; Yu-Sheng Li; Wen-Feng Xiao; Zhen-Han Deng; Hong-Bo He; Qing Liu; Wei Luo
Journal:  Biosci Rep       Date:  2017-05-17       Impact factor: 3.840

10.  Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.

Authors:  Weidong Li; Xiaobo Miao; Lingling Liu; Yue Zhang; Xuejun Jin; Xiaojun Luo; Hai Gao; Xubin Deng
Journal:  Oncotarget       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.